CTEPH Advisor (@ctephadvisor) 's Twitter Profile
CTEPH Advisor

@ctephadvisor

A resource about chronic thromboembolic pulmonary hypertension (CTEPH), a rare form of pulmonary hypertension. Terms of Use: bit.ly/ctephadvisor

ID: 3460513096

linkhttp://www.cteph.com calendar_today27-08-2015 18:48:04

451 Tweet

1,1K Followers

75 Following

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

Learn more about a type of #PH that is potentially surgically curable. Ask your Dr and click bit.ly/r@nd0m for information about #CTEPH

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

Myth: Ill patients can’t have pulmonary thromboendarterectomy surgery, a potentially curative #CTEPH treatment bit.ly/r@nd0m #HCP

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

#CTEPH is a potentially surgically curable form of #PH: up to 1 in 25 w/ a treated blood clot may be at risk. Talk to your Dr bit.ly/r@nd0m

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

Myth: #PTE surgery has a high mortality rate. Fact: Experienced centers can see mortality rates below 5% #CTEPH bit.ly/1W44im1 #HCP

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

#CTEPH is only type of #PH that can be cured with a surgery called pulmonary thromboendarterectomy (PTE) Talk to Dr bit.ly/1KnD7dA

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

As many as 1/25 previously treated PE patients (>3 mos anticoagulation) could develop form of PH called #CTEPH bit.ly/24fYcmI #HCP

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

True or False: A ventilation/perfusion (V/Q) scan showing perfusion defects is sufficient to diagnose #CTEPH bit.ly/1LhsEpj #HCP

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

Patient has Dyspnea 3 months after anticoagulation therapy for a PE? Learn about what to do next at bit.ly/1KqM0ra #CTEPH #HCP

CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

Bayer is offering the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards. Bayer is providing up to $1 million in grants over a 2-year period to support clinical research in pulmonary hypertension with focus on PAH & CTEPH. Visit PHAB-Awards.com to learn more.

Bayer is offering the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards. Bayer is
providing up to $1 million in grants over a 2-year period to support clinical research in
pulmonary hypertension with focus on PAH & CTEPH. Visit PHAB-Awards.com to learn more.
CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

The deadline to submit your letter of intent for the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards grant program is July 14th. Visit PHAB-Awards.com to learn more.

The deadline to submit your letter of intent for the Pulmonary Hypertension Accelerated Bayer
(PHAB) Awards grant program is July 14th. Visit PHAB-Awards.com to learn more.
CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

Sunday, July 14th is the deadline to submit your letter of intent for the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards. Visit PHAB-Awards.com to learn more.

Sunday, July 14th is the deadline to submit your letter of intent for the Pulmonary
Hypertension Accelerated Bayer (PHAB) Awards. Visit PHAB-Awards.com to learn more.
CTEPH Advisor (@ctephadvisor) 's Twitter Profile Photo

COVID-19 poses unique challenges for CTEPH. Join our 4/21/20 webinar to learn more: 6:30PM ET myspeakerbureau.com/6vQ6BA Enter program #: BAY0000376; State: New Jersey 8:30PM ET myspeakerbureau.com/1lG6C3 Enter program #: BAY0000377; State: New Jersey

COVID-19 poses unique challenges for CTEPH. Join our 4/21/20 webinar to learn more:

6:30PM ET myspeakerbureau.com/6vQ6BA Enter program #: BAY0000376; State: New Jersey

8:30PM ET myspeakerbureau.com/1lG6C3 Enter program #: BAY0000377; State: New Jersey